Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP)

NATerminatedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

September 2, 2020

Study Completion Date

September 2, 2020

Conditions
COPD
Interventions
DEVICE

Portable Oxygen Concentrator (POC)

COPD patients prescribed with LTOT will be randomized to receive a portable oxygen concentrator (POC)

Trial Locations (11)

15213

UPMC Emphysema/COPD Research Center, Pittsburgh

40218

Kentucky Research Group, Louisville

46260

St. Vincent Airways, Indianapolis

48106

ClinSite LLC, Ann Arbor

52242

University of Iowa, Iowa City

55125

Minnesota Lung Center, Woodbury

55407

Minnesota Lung Center, Minneapolis

55435

Minnesota Lung Center, Edina

60608

University of Illinois, Chicago, Chicago

80206

National Jewish Health, Denver

89106

Sierra Clinical Research, Las Vegas

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Inogen Inc.

INDUSTRY

lead

ResMed

INDUSTRY